Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
Sebastian J. Padayatty, Arie Katz, Yaohui Wang, Peter Eck, Oran Kwon, Je‐Hyuk Lee, Shenglin Chen, Christopher Peter Corpe, Anand Dutta, Sudhir Dutta, Mark Levine
Journal of the American College of Nutrition · 2003 · 2,012 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Padayatty, S. J., Katz, A., Wang, Y., Eck, P., Kwon, O., Lee, J., Chen, S., Corpe, C. P., Dutta, A., Dutta, S., & Levine, M. (2003). Vitamin C as an antioxidant: Evaluation of its role in disease prevention. Journal of the American College of Nutrition, 22(1), 18–35. https://doi.org/10.1080/07315724.2003.10719272
In text: (Padayatty et al., 2003)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Vitamin C in humans must be ingested for survival. Vitamin C is an electron donor, and this property accounts for all its known functions. As an electron donor, vitamin C is a potent water-soluble antioxidant in humans. Antioxidant effects of vitamin C have been demonstrated in many experiments in vitro. Human diseases such as atherosclerosis and cancer might occur in part from oxidant damage to tissues. Oxidation of lipids, proteins and DNA results in specific oxidation products that can be measured in the laboratory. While these biomarkers of oxidation have been measured in humans, such assays have not yet been validated or standardized, and the relationship of oxidant markers to human disease conditions is not clear. Epidemiological studies show that diets high in fruits and vegetables are associated with lower risk of cardiovascular disease, stroke and cancer, and with increased longevity. Whether these protective effects are directly attributable to vitamin C is not known. Intervention studies with vitamin C have shown no change in markers of oxidation or clinical benefit. Dose concentration studies of vitamin C in healthy people showed a sigmoidal relationship between oral dose and plasma and tissue vitamin C concentrations. Hence, optimal dosing is critical to intervention studies using vitamin C. Ideally, future studies of antioxidant actions of vitamin C should target selected patient groups. These groups should be known to have increased oxidative damage as assessed by a reliable biomarker or should have high morbidity and mortality due to diseases thought to be caused or exacerbated by oxidant damage.
Related papers
- Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents1965
- The Chemistry behind Antioxidant Capacity Assays2005
- Flavonoids: an overview2016
- Oxidants, antioxidants, and the degenerative diseases of aging.1993
- Standardized Methods for the Determination of Antioxidant Capacity and Phenolics in Foods and Dietary Supplements2005
Metadata from OpenAlex (CC0). Citations are generated from the published record.